Full Press Release Details
Life Sciences Announces F-3 Filing
York/London, 23 January 2020 - Tiziana Life Sciences plc (Nasdaq: TLSA / AIM: TILS), a biotechnology company focusing on the discovery
and development of innovative therapeutics for inflammation and oncology indications, announces the Company has today filed a
Form F-3 with the Securities Exchange Commission. An F-3 filing is a shelf registration statement for securities which may enable
the Company to potentially conduct a future fundraising (but absent any specific terms at the current time).
| Tiziana Life Sciences plc Gabriele Cerrone, Chairman and founder | +44 (0)20 7495 2379 |
| Cairn Financial Advisers LLP (Nominated adviser) Liam Murray / Jo Turner | + 44 (0)20 7213 0880 |
| Shore Capital (Broker) Antonio Bossi / Fiona Conroy | +44 (0)20 7601 6125 |
news and updates from Tiziana Life Sciences plc by signing up to get email alerts straight to you on https://ir.tizianalifesciences